1Department of Neurology, Slagelse Hospital, 4200 Slagelse-DK, Sweden
2Division of Rehabilitation Medicine, Department of Clinical Sciences, Karolinska Institutet, Danderyd University Hospital, 182 88 Stockholm-SE, Sweden
*Corresponding Author: Homayoun Roshanisefat, Department of Neurology, Slagelse Hospital, 4200 Slagelse-DK, Sweden and Division of Rehabilitation Medicine, Department of Clinical Sciences, Karolinska Institutet, Danderyd University Hospital, 182 88 Stockholm-SE, Sweden. E-mail: email@example.com
Received: May 05, 2020; Published: July 28, 2020
Background: Coronavirus in trigeminal nerve (TGN) has for decades been studied as a candidate neurotropic virus associated with multiple sclerosis (MS). The novel coronavirus 2019 (COVID-19) outbreak in infected cases is challenging the whole immune system. The lesson from MS treatment and a new era of COVID-19 therapies are of value to review.
Method: Searched databases to identify the strongest evidence of biopsy, autopsy, and cerebrospinal fluid (CSF), when using keywords MS and coronavirus, from January 1940 to April 2020. The result presents a solid knowledge of biopsy and autopsy for the association of COVID-19 and MS, then COVID-19 single and combination therapies being evaluated as presented in clinical use or clinical trials and compare common sites with MS.
Results: All therapies with proven clinical efficacy against COVID-19 and its current deployment in COVID-19 and their common aspect with MS therapies (MSTR) and immunology are screened. Some MSTR despite some different side-effect e.g. risk for infection or cardiac arrest are candidates of being used as COVID-19 life-saving therapy.
Conclusion: This global health disaster caused by airborne virus COVID-19, has created a new break to learn more about MS etiology and this airborne agent and future drug choices when reviewing the five months COVID-19 data through significant medical reports on World Wide Web.
Keywords: Multiple Sclerosis; Coronavirus; Trigeminal Nerve; Biopsy; Autopsy; Immunology
Citation: Homayoun Roshanisefat. “Coronavirus and Multiple Sclerosis, Autopsy and Biopsy and Choice of Therapy". Acta Scientific Medical Sciences 4.8 (2020): 124-135.
Copyright: © 2020 Homayoun Roshanisefat. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.